Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

A genetically reshaped human IgG1 monoclonal antibody (CAMPATH-1H) was used to treat two patients with non-Hodgkin lymphoma. Doses of 1-20 mg daily were given intravenously for up to 43 days. In both patients lymphoma cells were cleared from the blood and bone marrow and splenomegaly resolved. One p...

Podrobná bibliografie
Hlavní autoři:	Hale, G, Dyer, M, Clark, MR, Phillips, J, Marcus, R, Riechmann, L, Winter, G, Waldmann, H
Médium:	Journal article
Jazyk:	English
Vydáno:	1988

Podobné jednotky

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
Autor: Dyer, M, a další
Vydáno: (1990)

Specificity of monoclonal antibody Campath-1.
Autor: Hale, G, a další
Vydáno: (1988)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
Autor: Hale, G, a další
Vydáno: (1994)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
Autor: Dyer, M, a další
Vydáno: (1988)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
Autor: Waldmann, H, a další
Vydáno: (1985)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
Autor: Lim, S, a další
Vydáno: (1993)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
Autor: Waldmann, H, a další
Vydáno: (1985)

Sustained remission of severe resistant autoimmune neutropenia with Campath-1H.
Autor: Killick, S, a další
Vydáno: (1997)

Reshaping human antibodies for therapy.
Autor: Riechmann, L, a další
Vydáno: (1988)

The CAMPATH-1 antigen (CDw52).
Autor: Hale, G, a další
Vydáno: (1990)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
Autor: Isaacs, J, a další
Vydáno: (1996)

CAMPATH: from concept to clinic.
Autor: Waldmann, H, a další
Vydáno: (2005)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Autor: Naparstek, E, a další
Vydáno: (1999)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
Autor: Friend, P, a další
Vydáno: (1991)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
Autor: Williams, R, a další
Vydáno: (2000)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
Autor: Isaacs, J, a další
Vydáno: (1995)

ISOTYPE VARIANTS OF CAMPATH-1 ANTIBODY - REQUIREMENTS FOR EFFECTIVE ANTIBODY ACTION INVIVO
Autor: Dyer, M, a další
Vydáno: (1989)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
Autor: Rebello, P, a další
Vydáno: (1999)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
Autor: Hale, G, a další
Vydáno: (1986)

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.
Autor: Dyer, M, a další
Vydáno: (1989)

Availability of Campath-1 antibodies for bone marrow transplantation.
Autor: Hale, G, a další
Vydáno: (1995)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
Autor: Newman, D, a další
Vydáno: (1995)

CAMPATH-1 MOAB IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA (ATP)
Autor: Lim, S, a další
Vydáno: (1993)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
Autor: Hale, G, a další
Vydáno: (1985)

CAMPATH-1H in inflammatory arthritis.
Autor: Watts, R, a další
Vydáno: (1993)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
Autor: Hale, G, a další
Vydáno: (1988)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
Autor: Hale, G, a další
Vydáno: (1996)

In vivo 'purging' of residual disease in CLL with Campath-1H.
Autor: Dyer, M, a další
Vydáno: (1997)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
Autor: Waldmann, H, a další
Vydáno: (1987)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
Autor: Naparstek, E, a další
Vydáno: (1993)

CAMPATH-IH in multiple sclerosis.
Autor: Moreau, T, a další
Vydáno: (1996)

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience.
Autor: Novitzky, N, a další
Vydáno: (2004)

Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen.
Autor: Xia, M, a další
Vydáno: (1993)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Autor: Lockwood, C, a další
Vydáno: (1993)

Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.
Autor: Russell, N, a další
Vydáno: (1999)

CAMPATH-1 antibodies in stem-cell transplantation.
Autor: Hale, G, a další
Vydáno: (2001)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
Autor: Waldmann, H, a další
Vydáno: (2001)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
Autor: Watts, R, a další
Vydáno: (1992)

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Autor: Hale, G, a další
Vydáno: (2002)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
Autor: Hale, G, a další
Vydáno: (1998)